Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy

Clin Gastroenterol Hepatol. 2019 Mar;17(4):794-796. doi: 10.1016/j.cgh.2018.08.017. Epub 2018 Aug 13.

Authors

Catherine Le Berre¹, Damien Loeuille², Laurent Peyrin-Biroulet³

Affiliations

¹ Institut des Maladies de l'Appareil Digestif, Nantes University Hospital, Nantes, France.
² Department of Rheumatology, Nancy University Hospital, Nancy, Université de Lorraine, France.
³ Inserm U954, Department of Gastroenterology, Nancy University Hospital, Nancy, Université de Lorraine, France.

PMID: 30114486
DOI: 10.1016/j.cgh.2018.08.017

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Biological Products*
Colitis, Ulcerative*
Humans
Piperidines
Pyrimidines
Pyrroles
Spondylarthropathies*

Substances

Antibodies, Monoclonal, Humanized
Biological Products
Piperidines
Pyrimidines
Pyrroles
tofacitinib
vedolizumab